Clinical trials
Recruiting Lung Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| Beijing Chao Yang Hospital | 1 |
| Chang Chen | 1 |
| Chinese Academy of Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| ChromX Health | 1 |
| GlaxoSmithKline | 1 |
| Guangzhou JOYO Pharma Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 23 |
| Lung Neoplasms | 9 |
| Respiratory Tract Diseases | 8 |
| Neoplasms | 6 |
| Thoracic Neoplasms | 6 |
| Neoplasms by Site | 5 |
| Respiratory Tract Neoplasms | 5 |
| Bronchial Neoplasms | 4 |
| Carcinoma, Bronchogenic | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.